Testing effectiveness (Phase 2)Study completedNCT06266091
What this trial is testing
Treat Malignant Ascites Caused by Gastrointestinal or Ovarian Cancer With M701 Bispecific Antibody
Who this might be right for
Malignant Ascites
Wuhan YZY Biopharma Co., Ltd. 115